Literature DB >> 21756036

Biomarkers for bacteremia and severe sepsis in hematological patients with neutropenic fever: multivariate logistic regression analysis and factor analysis.

Auni Juutilainen1, Sari Hämäläinen, Kari Pulkki, Taru Kuittinen, Tapio Nousiainen, Esa Jantunen, Irma Koivula.   

Abstract

We compared biomarkers and their changes as predictors for bacteremia and severe sepsis during neutropenic fever after intensive chemotherapy in hematological patients. Serum C-reactive protein (CRP), semi-quantative procalcitonin, aminoterminal pro-brain natriuretic peptide (NT-proBNP), cortisol, lactate, plasma antithrombin and fibrinogen were measured daily from day 0 to day 3/day 4 in 89 neutropenic fever episodes of 65 hematological patients. The best predictors for bacteremia and gram-negative bacteremia were procalcitonin and its change, with odds ratios (ORs) and 95% confidence intervals of 2.63 (1.56-4.44) and 3.20 (1.77-5.80) for bacteremia and 4.14 (2.00-8.58) and 5.04 (2.18-11.63) for gram-negative bacteremia, respectively. For severe sepsis, the best predictors were CRP and fibrinogen, with ORs of 1.94 (1.07-3.52) and 1.92 (1.05-3.54). Factor analysis provided two predictive factors: procalcitonin-NT-proBNP-antithrombin factor predicted gram-negative bacteremia and CRP-fibrinogen predicted severe sepsis. Applying a combination of markers reflecting different aspects of infection might improve the recognition of risk for complications in patients with neutropenic fever.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21756036     DOI: 10.3109/10428194.2011.597904

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  11 in total

1.  Relationship of serum mannose-binding lectin levels with the development of sepsis: a meta-analysis.

Authors:  Dong-Na Gao; Yu Zhang; Yan-Bo Ren; Jian Kang; Li Jiang; Zhuo Feng; Ya-Nan Qu; Qing-Hui Qi; Xuan Meng
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

2.  Perspectives on the Immune System in Sepsis.

Authors:  Felician Stancioiu; Bogdan Ivanescu; Radu Dumitrescu
Journal:  Maedica (Bucur)       Date:  2022-06

3.  Procalcitonin and C-Reactive Protein As Markers of Bacteremia in Patients With Febrile Neutropenia Who Receive Chemotherapy for Acute Leukemia: A Prospective Study From Nepal.

Authors:  Ramila Shilpakar; Bishnu Dutta Paudel; Prakash Neupane; Aarati Shah; Bibek Acharya; Soniya Dulal; Lori Anne Wood; Rukmani Shahi; Usha Khanal; Bishesh Sharma Poudyal
Journal:  J Glob Oncol       Date:  2019-09

4.  Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia.

Authors:  Sini Korpelainen; Carina Intke; Sari Hämäläinen; Esa Jantunen; Auni Juutilainen; Kari Pulkki
Journal:  Dis Markers       Date:  2017-08-06       Impact factor: 3.434

Review 5.  Biomarkers of sepsis: time for a reappraisal.

Authors:  Charalampos Pierrakos; Dimitrios Velissaris; Max Bisdorff; John C Marshall; Jean-Louis Vincent
Journal:  Crit Care       Date:  2020-06-05       Impact factor: 9.097

Review 6.  Understanding and Managing Sepsis in Patients With Cancer in the Era of Antimicrobial Resistance.

Authors:  Carlota Gudiol; Adaia Albasanz-Puig; Guillermo Cuervo; Jordi Carratalà
Journal:  Front Med (Lausanne)       Date:  2021-03-31

7.  Utility of procalcitonin as a predictor of bloodstream infections and supportive modality requirements in critically ill cancer patients.

Authors:  Amanda G Blouin; Meier Hsu; Martin Fleisher; Lakshmi V Ramanathan; Stephen M Pastores
Journal:  Clin Chim Acta       Date:  2020-07-15       Impact factor: 3.786

8.  Diagnostic value of serum procalcitonin, lactate, and high-sensitivity C-reactive protein for predicting bacteremia in adult patients in the emergency department.

Authors:  Chiung-Tsung Lin; Jang-Jih Lu; Yu-Ching Chen; Victor C Kok; Jorng-Tzong Horng
Journal:  PeerJ       Date:  2017-11-27       Impact factor: 2.984

9.  Fatal hemorrhagic pneumonia in patients with hematologic diseases and Stenotrophomonas maltophilia bacteremia: a retrospective study.

Authors:  Lixia Zhu; Lulu Wang; Yuping Zhang; Rongrong Chen; Xueying Li; Jianai Sun; Mingyu Zhu; Xiaolong Zheng; Li Li; Jingjing Zhu; Mixue Xie; Xiudi Yang; Wenjuan Yu; Hongyan Tong; Honghu Zhu; Wanzhuo Xie; Jie Jin; Xiujin Ye
Journal:  BMC Infect Dis       Date:  2021-07-31       Impact factor: 3.090

10.  Antimicrobial prophylaxis and post-chemotherapy neutropenic fever in patients with leukemia: comparisons of C-reactive protein, procalcitonin and immediate fever outcome measures between those with and without prophylaxis, and the implications for practice.

Authors:  Choi Wan Chan; Alex Molassiotis; Harold K K Lee
Journal:  Support Care Cancer       Date:  2021-06-08       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.